CRN on ODS
This article was originally published in The Tan Sheet
Executive Summary
NIH's Office of Dietary Supplements "should overtly and in a transparent manner offer its reports as advice," CRN VP-Scientific & International Affairs John Hathcock, PhD, said in materials presented during a meeting on ODS' five-year Strategic Plan May 20 in Bethesda, Md. Hathcock noted that some needs are not being met to expand outreach to the public, scientists and healthcare providers. The CRN VP also recommended that the HHS secretary and agency heads at CDC and NIH "should overtly seek and consider the advice of ODS on [dietary supplement] issues"...
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.